123 related articles for article (PubMed ID: 12789387)
1. Clinical course of penile fibrosis in intracavernosal prostaglandin E1 injection therapy: a follow-up of 44 patients.
Chew KK; Stuckey BG
Int J Impot Res; 2003 Apr; 15(2):94-8. PubMed ID: 12789387
[TBL] [Abstract][Full Text] [Related]
2. Intracavernosal prostaglandin E1 self vs office injection therapy in patients with erectile dysfunction.
El-Sakka AI
Int J Impot Res; 2006; 18(2):180-5. PubMed ID: 16163370
[TBL] [Abstract][Full Text] [Related]
3. Penile scarring with intracavernous injection therapy using prostaglandin E1: a risk factor analysis.
Chen RN; Lakin MM; Montague DK; Ausmundson S
J Urol; 1996 Jan; 155(1):138-40. PubMed ID: 7490812
[TBL] [Abstract][Full Text] [Related]
4. Penile fibrosis in intracavernosal prostaglandin E1 injection therapy for erectile dysfunction.
Chew KK; Stuckey BG; Earle CM; Dhaliwal SS; Keogh EJ
Int J Impot Res; 1997 Dec; 9(4):225-9; discussion 229-30. PubMed ID: 9442421
[TBL] [Abstract][Full Text] [Related]
5. The long-term safety of alprostadil (prostaglandin-E1) in patients with erectile dysfunction. The European Alprostadil Study Group.
Br J Urol; 1998 Oct; 82(4):538-43. PubMed ID: 9806184
[TBL] [Abstract][Full Text] [Related]
6. Nocturnal penile tumescence activity unchanged after long-term intracavernous injection therapy.
Maniam P; Seftel AD; Corty EW; Rutchik SD; Hampel N; Althof SE
J Urol; 2001 Mar; 165(3):830-2; discussion 832-3. PubMed ID: 11176480
[TBL] [Abstract][Full Text] [Related]
7. Intracavernous self-injection of prostaglandin E1 in the therapy of erectile dysfunction.
Porst H; van Ahlen H; Block T; Halbig W; Hautmann R; Löchner-Ernst D; Rudnick J; Staehler G; Weber HM; Weidner W
Vasa Suppl; 1989; 28():50-6. PubMed ID: 2609244
[TBL] [Abstract][Full Text] [Related]
8. [Intracavernous auto-injection of prostaglandin E1 for diagnosis and treatment of erectile dysfunction].
Arielly J; Weinberg D; Eliraz A; Adam M; el-Hanani BI; Eisenkraft S
Harefuah; 1994 Apr; 126(7):369-73, 426. PubMed ID: 8200581
[TBL] [Abstract][Full Text] [Related]
9. Cavernous auto-injection therapy with prostaglandin E1.
Nisén H
Ann Chir Gynaecol Suppl; 1993; 206():69-73. PubMed ID: 8291874
[TBL] [Abstract][Full Text] [Related]
10. Intracavernous pharmacotherapy: comparison of Moxisylyte and prostaglandin E1.
Buvat J; Lemaire A; Herbaut-Buvat M
Int J Impot Res; 1996 Jun; 8(2):41-6. PubMed ID: 8858388
[TBL] [Abstract][Full Text] [Related]
11. Slow injection of prostaglandin E1 decreases associated penile pain.
Gheorghiu D; Godschalk M; Gheorghiu S; Mulligan T
Urology; 1996 Jun; 47(6):903-4. PubMed ID: 8677586
[TBL] [Abstract][Full Text] [Related]
12. Relation between intracavernosal dose of prostaglandin Pge 1 and mean duration of erection in men with different underlying causes of erectile dysfunction.
Bratus D; Hlebic G; Hajdinjak T
Croat Med J; 2007 Feb; 48(1):76-80. PubMed ID: 17309142
[TBL] [Abstract][Full Text] [Related]
13. Comparison of intraurethral liposomal and intracavernosal prostaglandin-E1 in the management of erectile dysfunction.
Engelhardt PF; Plas E; Hübner WA; Pflüger H
Br J Urol; 1998 Mar; 81(3):441-4. PubMed ID: 9523667
[TBL] [Abstract][Full Text] [Related]
14. [Intracavernous injection of lipo prostaglandin E1 for the diagnosis of impotence: a comparative study with prostaglandin E1-CD].
Yajima M; Baba K; Minagawa N; Kohno S; Haraguchi C; Iwamoto T; Osada T
Hinyokika Kiyo; 1993 Mar; 39(3):289-92. PubMed ID: 8506803
[TBL] [Abstract][Full Text] [Related]
15. MUSE therapy: preliminary clinical observations.
Werthman P; Rajfer J
Urology; 1997 Nov; 50(5):809-11. PubMed ID: 9372900
[TBL] [Abstract][Full Text] [Related]
16. [Erectile response to intracavernous injection of linsidomine in 38 impotent patients. Comparison with prostaglandin E1].
Lemaire A; Buvat J
Prog Urol; 1998 Jun; 8(3):388-91. PubMed ID: 9689672
[TBL] [Abstract][Full Text] [Related]
17. Long-term intracavernous therapy responders can potentially switch to sildenafil citrate after radical prostatectomy.
Raina R; Lakin MM; Agarwal A; Ausmundson S; Montague DK; Zippe CD
Urology; 2004 Mar; 63(3):532-7; discussion 538. PubMed ID: 15028452
[TBL] [Abstract][Full Text] [Related]
18. Treatment satisfaction in patients with erectile dysfunction switching from prostaglandin E(1) intracavernosal injection therapy to oral sildenafil citrate.
Montorsi F; Althof SE; Sweeney M; Menchini-Fabris F; Sasso F; Giuliano F
Int J Impot Res; 2003 Dec; 15(6):444-9. PubMed ID: 14671665
[TBL] [Abstract][Full Text] [Related]
19. Long-term treatment with intracavernosal injections in diabetic men with erectile dysfunction.
Perimenis P; Konstantinopoulos A; Perimeni PP; Gyftopoulos K; Kartsanis G; Liatsikos E; Athanasopoulos A
Asian J Androl; 2006 Mar; 8(2):219-24. PubMed ID: 16491275
[TBL] [Abstract][Full Text] [Related]
20. Incidence of penile pain after injection of a new formulation of prostaglandin E1.
Chen J; Godschalk MF; Katz PG; Mulligan T
J Urol; 1995 Jul; 154(1):77-9. PubMed ID: 7776460
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
